Our translational science

We're tackling the biggest challenges in developing cancer treatments with our innovative approach to drug discovery and development.

Our bold drug discovery model embraces risk to drive forward early-stage projects, with a focus on creating a pipeline of breakthrough medicines for cancer patients.

Scientist wearing a white lab coat and goggle looking at some equipment.

Expertise spanning drug discovery and development

We build on Cancer Research UK's impressive track record of innovative research to bridge the gap between academia and the life science industry. We're committed to driving therapeutic innovation in oncology, with four drug discovery sites and one focus: accelerating the discovery and development of new therapeutics.

Blond woman working in a fume hood in a laboratory.

Drug discovery

Our drug discovery expertise spans the full translational pathway. Working in partnership with research and industry partners, we provide the scientific expertise, capabilities and infrastructure needed to transform promising cancer research into clinical opportunities.

Explore our drug discovery offering
Scientist working in a lab looking at a test tube.

Clinical development

Our partnership with the Cancer Research UK Centre for Drug Development (CDD) offers the capabilities and infrastructure needed to demonstrate clinical potential

With a team of over 100 scientists and operational staff, their clinical expertise spans the full breadth of drug development.

Find out more about the CDD
Group of scientists in blue lab coats looking at a white board.

Spotlight on our Functional Genomics Centre

Our state-of-the-art Functional Genomics Centre (FGC) leverages the combined global strengths of Cancer Research UK’s world-class scientific network and AstraZeneca’s oncology drug discovery and development experience to drive scientific innovation.

"The Functional Genomics Centre's team have helped identify networks of genes we didn't predict, shaping our research strategy for the next years."

- Professor Jo Morris, University of Birmingham

Learn about the FGC
Two woman speak to each other on an inside balcony, with the photo taken from the floor

Partnering and licensing

Looking for more information on licensing, therapeutic alliances or other partnership opportunities leveraging our drug discovery expertise?

Our partnering model is built on collaboration across academia and industry. 

We combine our end-to-end drug discovery expertise with external innovation through licensing opportunities and strategic alliances. Partners can also access and develop assets from our own research pipeline.

Contact us to learn more

Our news

Other ways we can help

A scientist wearing google and a lab coat examining a sample.

Researchers

We support innovative research that can benefit society. Let us help you turn your ideas into meaningful progress for patients.

Woman speaking to man

Partners

We de-risk innovation by turning promising science into high-value assets. Partner with us for access to our extensive network and portfolio.

Scientist in lab in white lab coat

CancerTools

Discover CancerTools, our non-profit, global research tools collaborative comprised of cancer researchers, academic institutes and societies.

Interested in working with us?

We collaborate with research and industry partners to progress promising cancer research. Whether you're exploring a novel target, developing a research asset or seeking a strategic partnership, we want to hear from you.

Contact us